Mulmit

Oruka Therapeutics, Inc.Oruka Therapeutics, Inc.

ORKA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2023-12-310-7,296,000-5,339,000-0.37
2022-12-310-10,596,000-9,926,000-0.69
2021-12-310-19,335,000-19,322,000-1.39
2020-12-310-9,766,000-9,738,000
2019-12-310-5,814,000-5,482,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-01Sandler Laura LeeChief Operating Officer5,000
2026-09-01Sandler Laura LeeChief Operating Officer1,000
2026-09-01Sandler Laura LeeChief Operating Officer4,000
2026-09-01Sandler Laura LeeChief Operating Officer5,000
2026-09-01Klein Lawrence OttoChief Executive Officer75,000
2026-09-01Klein Lawrence OttoChief Executive Officer6,604
2026-09-01Klein Lawrence OttoChief Executive Officer63,596
2026-09-01Klein Lawrence OttoChief Executive Officer4,800
2026-09-01Klein Lawrence OttoChief Executive Officer75,000
2026-08-24Edwards Larry ToddChief Commercial Officer100,000
2026-08-24Edwards Larry ToddChief Commercial Officer20,000
2026-08-17Goncalves JoanaChief Medical Officer3,500

8-K events

FiledItems
2026-08-24Officer or director change · Financial statements and exhibits
2026-08-10Results of operations · Financial statements and exhibits
2026-06-04Submission of matters to a vote
2026-06-01Other events · Financial statements and exhibits
2026-04-30Results of operations · Other events · Financial statements and exhibits
2026-04-27Regulation FD disclosure · Other events · Financial statements and exhibits
2025-12-11Officer or director change · Financial statements and exhibits
2025-09-22Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…